Stock Track | TransMedics Stock Plunges After Q3 Earnings Miss

Stock Track10-30

Shares of TransMedics Group, Inc. (NASDAQ: TMDX) plummeted 5.05% on Tuesday, October 30th, 2024, following the company's disappointing third-quarter earnings report. Despite reporting revenue growth and moving to profitability compared to the same period last year, TransMedics missed analyst expectations for both revenue and earnings per share.

The medical device company reported revenue of $108.8 million for the third quarter of 2024, up 64% year-over-year, but missing analyst estimates by 5.4%. Meanwhile, TransMedics posted earnings per share of $0.13, which fell short of analyst expectations by 62%.

TransMedics' stock had already been under pressure, declining 25% in the week leading up to the earnings release. The disappointing Q3 results and missed expectations further exacerbated the sell-off, with investors expressing concerns about the company's growth trajectory and ability to meet financial targets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1130892128?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-30 21:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130892128","market":"us","top_or_hot":-1,"title":"Stock Track | TransMedics Stock Plunges After Q3 Earnings Miss","media":"Stock Track","content":"<p>Shares of TransMedics Group, Inc. (NASDAQ: TMDX) plummeted 5.05% on Tuesday, October 30th, 2024, following the company's disappointing third-quarter earnings report. Despite reporting revenue growth and moving to profitability compared to the same period last year, TransMedics missed analyst expectations for both revenue and earnings per share.</p>\n\n<p>The medical device company reported revenue of $108.8 million for the third quarter of 2024, up 64% year-over-year, but missing analyst estimates by 5.4%. Meanwhile, TransMedics posted earnings per share of $0.13, which fell short of analyst expectations by 62%.</p>\n\n<p>TransMedics' stock had already been under pressure, declining 25% in the week leading up to the earnings release. The disappointing Q3 results and missed expectations further exacerbated the sell-off, with investors expressing concerns about the company's growth trajectory and ability to meet financial targets.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | TransMedics Stock Plunges After Q3 Earnings Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | TransMedics Stock Plunges After Q3 Earnings Miss\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-30 21:46 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of TransMedics Group, Inc. (NASDAQ: TMDX) plummeted 5.05% on Tuesday, October 30th, 2024, following the company's disappointing third-quarter earnings report. Despite reporting revenue growth ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMDX","symbol_name":"TransMedics Group Inc.","start_time":0,"source_url":"","article_id":"1130892128","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130892128","pubTimestamp":1730295974,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of TransMedics Group, Inc.  plummeted 5.05% on Tuesday, October 30th, 2024, following the company's disappointing third-quarter earnings report. Despite reporting revenue growth and moving to profitability compared to the same period last year, TransMedics missed analyst expectations for both revenue and earnings per share.The medical device company reported revenue of $108.8 million for the third quarter of 2024, up 64% year-over-year, but missing analyst estimates by 5.4%. Meanwhile, Tr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMDX":"TransMedics Group Inc."},"translate_title":"股票追踪TransMedics股价在第三季度盈利未达预期后暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMDX":1},"content_text":"Shares of TransMedics Group, Inc. (NASDAQ: TMDX) plummeted 5.05% on Tuesday, October 30th, 2024, following the company's disappointing third-quarter earnings report. Despite reporting revenue growth and moving to profitability compared to the same period last year, TransMedics missed analyst expectations for both revenue and earnings per share.\nThe medical device company reported revenue of $108.8 million for the third quarter of 2024, up 64% year-over-year, but missing analyst estimates by 5.4%. Meanwhile, TransMedics posted earnings per share of $0.13, which fell short of analyst expectations by 62%.\nTransMedics' stock had already been under pressure, declining 25% in the week leading up to the earnings release. The disappointing Q3 results and missed expectations further exacerbated the sell-off, with investors expressing concerns about the company's growth trajectory and ability to meet financial targets.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1130892128"}